Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer
van Baardwijk, Angela × Reymen, Bart Wanders, Stofferinus Borger, Jacques Ollers, Michel Dingemans, Anne-Marie C Bootsma, Gerben Geraedts, Wiel Pitz, Cordula Lunde, Ragnar Peters, Frank Lambin, Philippe De Ruysscher, Dirk #
European Journal of Cancer vol:48 issue:15 pages:2339-2346
Sequential chemotherapy and individualised accelerated radiotherapy (INDAR) has been shown to be effective in non-small cell lung cancer (NSCLC), allowing delivering of high biological doses. We therefore performed a phase II trial (clinicaltrials.gov; NCT00572325) investigating the same strategy in concurrent chemo-radiation in stage III NSCLC.